DrugsDisclosed.com Launches ‘Medication Trustpilot’ to Amplify Patient Voices

September 10, 2020
Pharmaceutical Executive Editors

Review platform launches in light of new research which reveals that 93% lack trust in pharma companies.

DrugsDisclosed.com launched today to give patients more control over their own treatments to share real world experiences of their medicines. Alongside today’s launch, new research underlines the need for pharmaceutical companies to better listen and learn from these experiences — with a ‘trust deficit’ opening up between patients and the industry that develops and produces their medicines.

DrugsDisclosed.com is a review platform that offers patients the chance to quickly share and compare their experiences with others using the same medications. The site collates data from over 352,044 unique patient medication reviews from the associated DrugStars medication management app.

Trust deficit

The need for patients to be heard is confirmed in research commissioned by DrugsDisclosed.com and market research partner Userneeds. Results reveal that patients feel ignored once medicines go to market and regard pharmaceutical companies with suspicion. The survey of more than a thousand users of prescription and over the counter (OTC) medicines from the UK and Ireland revealed:

  • 93% of patients do not trust advice from pharmaceutical companies about their medication
  • 84% feel the pharmaceutical industry influences prescription decisions
  • 68% expressed a desire to be able to feedback their experiences to pharma companies
  • 81% of patients do not feel listened to by pharmaceutical companies

Related Content:

News